Search results for "Diazepine"

showing 10 items of 108 documents

Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spe…

2004

Abstract An automated HPLC method with column switching is described for the determination of quetiapine, clozapine, perazine, olanzapine and metabolites in blood serum. After clean-up on silica C8 material (20 μm particle size) drugs were separated on ODS Hypersil C18 material (5 μm; column size 250 mm × 4.6 mm i.d.) within 25 min and quantified by ultraviolet (UV) detection at 254 nm. The limit of quantification ranged between 10 and 50 ng/ml. At therapeutic concentrations of the drugs, the inter-assay reproducibility was below 10%. Analyses of drug concentrations in serum of 75–295 patients treated with therapeutic doses of the antipsychotic drugs revealed mean ± S.D. steady state concen…

DrugDibenzothiazepinesmedicine.drug_classmedia_common.quotation_subjectClinical BiochemistryAtypical antipsychoticPharmacologyBiochemistryHigh-performance liquid chromatographyAnalytical ChemistryPerazineBenzodiazepinesQuetiapine FumarateColumn chromatographyBlood serummedicineHumansClozapineChromatography High Pressure Liquidmedia_commonChromatographymedicine.diagnostic_testChemistryReproducibility of ResultsCell BiologyGeneral MedicinePerazineTherapeutic drug monitoringOlanzapineCalibrationQuetiapineSpectrophotometry Ultravioletmedicine.drugAntipsychotic AgentsJournal of chromatography. B, Analytical technologies in the biomedical and life sciences
researchProduct

Effects of the benzodiazepine receptor agonist midazolam and antagonist flumazenil on 5-hydroxytryptamine release from guinea-pig intestine in vitro

1990

Isolated segments of the guinea-pig small intestine and the guinea-pig stomach were vascularly perfused and the release of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid into the portal venous effluent determined by high pressure liquid chromatography with electrochemical detection. Test substances were applied intraarterially. The benzodiazepine receptor agonist, midazolam, concentration-dependently increased (by 58%, at 1 nmol/l) and decreased (by 32%, at 100 nmol/l) the release of 5-HT from small intestine preparations. Both effects were blocked by the benzodiazepine receptor antagonist flumazenil (10 nmol/l) The stimulatory effect of midazolam was also abolished in the presen…

FlumazenilMaleAgonistSerotoninmedicine.medical_specialtymedicine.drug_classMidazolamGuinea PigsTetrodotoxinIn Vitro TechniquesBiologychemistry.chemical_compoundInternal medicineIntestine SmallElectrochemistrymedicineAnimalsChromatography High Pressure LiquidPharmacologyBenzodiazepineGABAA receptorStomachAntagonistGeneral MedicineHydroxyindoleacetic AcidBicucullineReceptors GABA-ASmall intestinePerfusionEndocrinologymedicine.anatomical_structurechemistryGastric MucosaFlumazenilChromaffin SystemTetrodotoxinFemalemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

[ 18 F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors

2001

5-(2'-[18F]Fluoroethyl)flumazenil ([18F]FEF) is a fluorine-18 labelled positron emission tomography (PET) tracer for central benzodiazepine receptors. Compared with the established [11C]flumazenil, it has the advantage of the longer half-life of the fluorine-18 label. After optimisation of its synthesis and determination of its in vitro receptor affinities, we performed first PET studies in humans. PET studies in seven healthy human volunteers were performed on a Siemens ECAT EXACT whole-body scanner after injection of 100-280 MBq [L8F]FEF. In two subjects, a second PET scan was conducted after pretreatment with unlabelled flumazenil (1 mg or 2.5 mg i.v., 3 min before tracer injection). A t…

FlumazenilMalemedicine.drug_classNuclear magnetic resonancemedicineHumansRadiology Nuclear Medicine and imagingReceptorTemporal cortexBenzodiazepineChemistrybusiness.industryGABAA receptorBrainHalf-lifeBinding potentialGeneral MedicineHuman brainReceptors GABA-Amedicine.anatomical_structureFlumazenilRadiopharmaceuticalsNuclear medicinebusinessTomography Emission-Computedmedicine.drugEuropean Journal of Nuclear Medicine and Molecular Imaging
researchProduct

Benzodiazepines for catatonic symptoms, stupor, and mutism.

1988

FlumazenilPediatricsmedicine.medical_specialtyDepressive DisorderDiazepamMutismbusiness.industryStuporCatatoniaGeneral MedicineLorazepamPsychiatry and Mental healthBenzodiazepinesAnti-Anxiety AgentsmedicineHumansPharmacology (medical)Femalemedicine.symptombusinessPharmacopsychiatry
researchProduct

The GABAergic effect of low doses of lorazepam on social behavior

2002

The aim of this work was to test the antiaggressive effects of lorazepam and to determine whether these effects were mediated by benzodiazepine receptors. In a first experiment, male mice were injected with lorazepam in a range of low doses (0.05, 0.1, 0.2, and 0.6 mg/kg) or saline solution. In a second experiment, 1 mg/kg of Ro 15-1788, a benzodiazepine receptor antagonist, and a saline solution were injected before the behavioral test. Results showed that 0.6 mg/kg of lorazepam was the only dose that decreased the total duration of threat ( P < .01) and social investigation ( P < .05) and that 1 mg/kg of Ro 15-1788 had no effects. In the third experiment, animals received two injec- tions…

GABAA receptorChemistrymedicine.medical_treatmentLow doseAntagonistMale micePoison controlLorazepamPharmacologyArts and Humanities (miscellaneous)Benzodiazepine Receptor AntagonistAnesthesiamental disordersDevelopmental and Educational PsychologymedicineSalineGeneral Psychologymedicine.drugAggressive Behavior
researchProduct

Benzodiazepine receptor interactions may be involved in the neurotoxicity of various penicillin derivatives

1980

The interaction of seven penicillin derivatives with specific [3H]flunitrazepam binding to benzodiazepine receptors was investigated. The affinities of the penicillins for benzodiazepine receptor seemed to depend on the lipophilia of the derivatives. The concentrations of the penicillins which inhibit specific [3H]flunitrazepam binding are consistent with penicillin levels found in the central nervous system of patients developing penicillin induced convulsions. The results suggest that penicillins inhibit GABAergic transmission not only at the GABA receptor, but also at the benzodiazepine receptor, which is thought to be part of a neuronal system facilitating GABAergic transmission. Both m…

Gabaergic transmissionBenzodiazepinemedicine.drug_classGABAA receptorChemistryCentral nervous systemNeurotoxicityPharmacologymedicine.diseasePenicillinmedicine.anatomical_structureNeurologyGABA receptorpolycyclic compoundsmedicineNeurology (clinical)Receptormedicine.drugAnnals of Neurology
researchProduct

The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

1998

The amino acid gamma-aminobutyric-acid (GABA) prevails in the CNS as an inhibitory neurotransmitter that mediates most of its effects through fast GABA-gated Cl(-)-channels (GABAAR). Molecular biology uncovered the complex subunit architecture of this receptor channel, in which a pentameric assembly derived from five of at least 17 mammalian subunits, grouped in the six classes alpha, beta, gamma, delta, sigma and epsilon, permits a vast number of putative receptor isoforms. The subunit composition of a particular receptor determines the specific effects of allosterical modulators of the GABAARs like benzodiazepines (BZs), barbiturates, steroids, some convulsants, polyvalent cations, and et…

Gene isoformMacromolecular SubstancesProtein ConformationProtein subunitNeuroscience (miscellaneous)LoreclezoleConvulsantsBiologyInhibitory postsynaptic potentialGABAA-rho receptorSubstrate SpecificityGABA AntagonistsCellular and Molecular NeuroscienceBenzodiazepinesMiceChloride ChannelsmedicineAnimalsHumansProtein IsoformsReceptorGABA Agonistsgamma-Aminobutyric AcidAnestheticsMice KnockoutBinding SitesIon TransportGABAA receptorReceptors GABA-ARecombinant ProteinsRatsElectrophysiologyNeurologyBiochemistryBarbituratesSteroidsHeterologous expressionIon Channel Gatingmedicine.drugMolecular neurobiology
researchProduct

Sensitive Screening of New Psychoactive Substances in Serum Using Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry.

2021

Abstract Analysis of new psychoactive substances (NPS) still poses a challenge for many institutions due to the number of available substances and the constantly changing drug market. Both new and well-known substances keep appearing and disappearing on the market, making it hard to adapt analytical methods in a timely manner. In this study we developed a qualitative screening approach for serum samples by means of liquid chromatography--quadrupole time-of-flight mass spectrometry. Samples were measured in data-dependent auto tandem mass spectrometry mode and identified by fragment spectra comparison, retention time and accurate mass. Approximately 500 NPS, including 195 synthetic cannabino…

Health Toxicology and MutagenesisToxicologyMass spectrometry01 natural sciencesMethcathinoneAnalytical Chemistry03 medical and health sciencesBenzodiazepines0302 clinical medicineTandem Mass SpectrometrySynthetic cannabinoidsmedicineEnvironmental Chemistry030216 legal & forensic medicineSolid phase extractionQuadrupole time of flightPsychotropic DrugsChemical Health and SafetyChromatographyChemistryElution010401 analytical chemistryReproducibility of ResultsSerum samples0104 chemical sciencesSubstance Abuse DetectionRetention timemedicine.drugChromatography LiquidJournal of analytical toxicology
researchProduct

Comparative studies on the detection of benzodiazepines in serum by means of immunoassays (FPIA).

1993

Serum was tested for benzodlazeplnes by fluorescence polarlzatlon Immunoassay (FPIA) on Abbott's ADx system uslng the benzodlazeplne serum reagents (Benzo S) and the benzodlazeplne urine reagents (Benzo U) after pretreatment of speclmens by means of acetone preclpltatlon. The followlng sera were included for comparing the two methods: negatlve sera spiked with varlous benzodlazeplnes; 80 sera randomly selected out of a total of 8654 serum specimens from Impalred drlvers; and blood speclmens from Indlvlduals who stated that they had taken benzodlazeplnes. The different benzodlazeplnes were added to serum st concentratlons of 25, 75, and 300 ng/mL. The low-dose benzodlazeplnes flunltrazepam a…

ImmunoassayChemical Health and SafetyChromatographymedicine.diagnostic_testChemistryHealth Toxicology and MutagenesisUrineCross ReactionsToxicologyBiological fluidAnalytical ChemistryBenzodiazepinesAntibody SpecificityImmunoassayFluorescence Polarization ImmunoassaymedicineFluorescence polarization immunoassayEnvironmental ChemistryHumansJournal of analytical toxicology
researchProduct

Diagnosis and therapeutic management of primary headache in an emergency setting

2013

Introduction and aim: Much headachers are under or mis-diagnoses and data regarding the proportion of patients attending an emergency department (ED) because of headache are still few. We conducted a retrospective observational study in an ED with the following aims: (a) estimate the proportion of headache attending to an ED (b) to estimate and describe the therapeutic management of primary headache and (c) to assessment the exam most frequently requested. Materials and methods: We collected data regarding patients diagnosed with headache consecutively attending the ED of the University of Palermo between September 2011 and March 2012. The study was approved by the ethics committee. Results: Between the semester evaluated 25110 subjects were admitted to ED headache suffers were equal to 1.6 %. Of these 263 (63.1 %) were woman and 154 (36.9 %). Mean age was 44.2 (DS ± 18.4) years (p = 0.068).According to ED registry headache admission was as follow assigned: 76.5 % with a diagnosis of headache 22.8 % with a secondary headache 0.7 % with Trigeminal Autonomic Cephalgias (TACs). Among those with a primary headache about 36 % of patient did not received a pharmacological treatment. Monotherapy was prescribed less frequently than combination therapy (19.1 vs 44.5 %).In monotherapy the most frequent medication were NSAIDs (28.3 %) benzodiazepines (26.7 %) and dopamine antagonists (11.7 %). Among those with a primary headache a CT scan was performed in the 124 subjects and 111 (34.8 %) had a neurologist consultation. Discussion: Our data are in line with the one previously reported in literature. The most frequently medication in the Italian ED were NSAIDs benzodiazepines dopamine antagonists and steroids. Neverless our data unlikely can be compared to other study give a snapshot. We believe that much more can be done to improve treatment of primary headache in ED.Settore MED/26 - Neurologia
researchProduct